Table 4. Pathways enriched with target genes predicted by an intersection of miRanda and TargetScan target lists for the 14q32 cluster.
Category | Term | n | % | P-value | Benjamini |
---|---|---|---|---|---|
KEGG_PATHWAY | Pathways in cancer | 31 | 3.8 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Prostate cancer | 13 | 1.6 | <0.0001 | <0.0001 |
KEGG_PATHWAY | MAPK signaling pathway | 21 | 2.6 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Focal adhesion | 18 | 2.2 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Melanoma | 11 | 1.4 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Adherens junction | 11 | 1.4 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Endocytosis | 16 | 2.0 | <0.0001 | <0.0001 |
KEGG_PATHWAY | mTOR signaling pathway | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Non-small-cell lung cancer | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Long-term potentiation | 10 | 1.2 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Chronic myeloid leukemia | 10 | 1.2 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Insulin signaling pathway | 13 | 1.6 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Regulation of actin cytoskeleton | 16 | 2.0 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Glioma | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Progesterone-mediated oocyte maturation | 10 | 1.2 | <0.0001 | <0.0001 |
KEGG_PATHWAY | ErbB signaling pathway | 10 | 1.2 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Renal cell carcinoma | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Jak-STAT signaling pathway | 13 | 1.6 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Pancreatic cancer | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Neurotrophin signaling pathway | 11 | 1.4 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Colorectal cancer | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Small-cell lung cancer | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Calcium signaling pathway | 13 | 1.6 | <0.0001 | <0.0001 |
KEGG_PATHWAY | TGF-β signaling pathway | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Dilated cardiomyopathy | 9 | 1.1 | <0.0001 | <0.0001 |
KEGG_PATHWAY | Phosphatidylinositol signaling system | 8 | 1.0 | <0.0001 | 0.0001 |
KEGG_PATHWAY | Fcγ R-mediated phagocytosis | 9 | 1.1 | <0.0001 | 0.0001 |
KEGG_PATHWAY | Acute myeloid leukemia | 7 | 0.9 | <0.0001 | 0.0002 |
KEGG_PATHWAY | HCM | 8 | 1.0 | 0.0001 | 0.0002 |
KEGG_PATHWAY | Melanogenesis | 9 | 1.1 | <0.0001 | 0.0002 |
KEGG_PATHWAY | Axon guidance | 10 | 1.2 | 0.0001 | 0.0002 |
KEGG_PATHWAY | Apoptosis | 8 | 1.0 | 0.0002 | 0.0003 |
KEGG_PATHWAY | Neuroactive ligand–receptor interaction | 14 | 1.7 | 0.0002 | 0.0003 |
KEGG_PATHWAY | Vascular smooth muscle contraction | 9 | 1.1 | 0.0002 | 0.0003 |
KEGG_PATHWAY | Long-term depression | 7 | 0.9 | 0.0003 | 0.0004 |
KEGG_PATHWAY | Wnt signaling pathway | 10 | 1.2 | 0.0004 | 0.0006 |
KEGG_PATHWAY | ARVC | 7 | 0.9 | 0.0004 | 0.0006 |
KEGG_PATHWAY | Fcɛ RI signaling pathway | 7 | 0.9 | 0.0005 | 0.0007 |
KEGG_PATHWAY | GnRH signaling pathway | 8 | 1.0 | 0.0005 | 0.0007 |
KEGG_PATHWAY | Tight junction | 9 | 1.1 | 0.0007 | 0.0009 |
KEGG_PATHWAY | Chemokine signaling pathway | 11 | 1.4 | 0.0007 | 0.0009 |
KEGG_PATHWAY | T-cell receptor signaling pathway | 8 | 1.0 | 0.0007 | 0.0009 |
KEGG_PATHWAY | Ubiquitin-mediated proteolysis | 9 | 1.1 | 0.0009 | 0.0011 |
KEGG_PATHWAY | Oocyte meiosis | 8 | 1.0 | 0.001 | 0.0012 |
KEGG_PATHWAY | Gap junction | 7 | 0.9 | 0.0012 | 0.0014 |
KEGG_PATHWAY | Leukocyte transendothelial migration | 8 | 1.0 | 0.0013 | 0.0015 |
KEGG_PATHWAY | Natural killer cell-mediated cytotoxicity | 8 | 1.0 | 0.0033 | 0.0037 |
KEGG_PATHWAY | Lysosome | 7 | 0.9 | 0.0052 | 0.0056 |
KEGG_PATHWAY | Huntington's disease | 9 | 1.1 | 0.0063 | 0.0067 |
KEGG_PATHWAY | CAMs | 7 | 0.9 | 0.0106 | 0.011 |
KEGG_PATHWAY | Cytokine–cytokine receptor interaction | 10 | 1.2 | 0.0227 | 0.0231 |
KEGG_PATHWAY | Metabolic pathways | 29 | 3.6 | 0.0268 | 0.0268 |
Abbreviations: ARVC, arrhythmogenic right ventricular cardiomyopathy; CAM, cell adhesion molecules; GnRH, gonadotropin-releasing hormone; HCM, hypertrophic cardiomyopathy; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin.
Enriched KEGG pathways identified by WebGestalt gene set analysis using predicted target genes. The list was compiled from an intersection of the miRanda and TargetScan predicted targets of 17 members of the miR-14q32 cluster differentially expressed in schizophrenia. n, number of input genes in pathway (filtered to only show pathways represented by ⩾7 target genes). %, percentage of total target genes analyzed (∼810 gene IDs) that are represented in this pathway.